CN100579535C - 免疫功能以及与之有关的改善 - Google Patents

免疫功能以及与之有关的改善 Download PDF

Info

Publication number
CN100579535C
CN100579535C CN03805094A CN03805094A CN100579535C CN 100579535 C CN100579535 C CN 100579535C CN 03805094 A CN03805094 A CN 03805094A CN 03805094 A CN03805094 A CN 03805094A CN 100579535 C CN100579535 C CN 100579535C
Authority
CN
China
Prior art keywords
unit dose
diindolylmethane
chrysin
resveratrol
psk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN03805094A
Other languages
English (en)
Chinese (zh)
Other versions
CN1638786A (zh
Inventor
迈克尔·唐纳德·法利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1638786A publication Critical patent/CN1638786A/zh
Application granted granted Critical
Publication of CN100579535C publication Critical patent/CN100579535C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN03805094A 2003-01-09 2003-01-09 免疫功能以及与之有关的改善 Expired - Fee Related CN100579535C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/000709 WO2004062683A1 (en) 2003-01-09 2003-01-09 Improvements in or relating to immune functions

Publications (2)

Publication Number Publication Date
CN1638786A CN1638786A (zh) 2005-07-13
CN100579535C true CN100579535C (zh) 2010-01-13

Family

ID=34885486

Family Applications (1)

Application Number Title Priority Date Filing Date
CN03805094A Expired - Fee Related CN100579535C (zh) 2003-01-09 2003-01-09 免疫功能以及与之有关的改善

Country Status (7)

Country Link
EP (1) EP1581238B1 (enExample)
JP (1) JP2006501308A (enExample)
CN (1) CN100579535C (enExample)
AT (1) ATE395925T1 (enExample)
DE (1) DE60321227D1 (enExample)
MX (1) MXPA04011768A (enExample)
WO (1) WO2004062683A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
ES2428665B1 (es) * 2012-05-04 2014-10-01 Universidad De Valladolid Composición para su uso en el tratamiento y/o prevención de la inflamación, el estrés oxidativo y la neovascularización ocular
CN106974904B (zh) * 2017-03-14 2020-07-28 南方医科大学 杨梅素及其衍生物的新用途和一种抗hiv感染的杀微生物剂
CN110772578A (zh) * 2019-11-11 2020-02-11 李胜 一种用于癌症防治的人体免疫力增强剂及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742012A2 (en) * 1995-05-10 1996-11-13 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
CN1230875A (zh) * 1996-09-20 1999-10-06 霍华德基金会 含黄酮醇的食品增补剂
WO1999049851A1 (en) * 1998-04-01 1999-10-07 Bioresponse, L.L.C. Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
WO2002062367A1 (en) * 2001-02-02 2002-08-15 Metagenics, Inc. Medical composition for managing hormone balance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742012A2 (en) * 1995-05-10 1996-11-13 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
CN1230875A (zh) * 1996-09-20 1999-10-06 霍华德基金会 含黄酮醇的食品增补剂
CN1230956A (zh) * 1996-09-20 1999-10-06 霍华德基金会 生产含多酚的组合物的方法
WO1999049851A1 (en) * 1998-04-01 1999-10-07 Bioresponse, L.L.C. Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
WO2002062367A1 (en) * 2001-02-02 2002-08-15 Metagenics, Inc. Medical composition for managing hormone balance

Also Published As

Publication number Publication date
DE60321227D1 (de) 2008-07-03
EP1581238B1 (en) 2008-05-21
MXPA04011768A (es) 2005-03-31
EP1581238A1 (en) 2005-10-05
HK1078471A1 (en) 2006-03-17
CN1638786A (zh) 2005-07-13
JP2006501308A (ja) 2006-01-12
WO2004062683A1 (en) 2004-07-29
ATE395925T1 (de) 2008-06-15

Similar Documents

Publication Publication Date Title
US6544564B1 (en) Cytotoxic pharmaceutical composition
Alhmied et al. Molecular mechanisms of thymoquinone as anticancer agent
Milić et al. New therapeutic potentials of milk thistle (Silybum marianum)
Kumar et al. Current clinical developments in curcumin‐based therapeutics for cancer and chronic diseases
ES2902136T3 (es) Composiciones farmacéuticas que comprenden un fármaco antirretrovírico y un potenciador farmacocinético
US6767563B2 (en) Immune functions
ES2804324T3 (es) Composiciones que contienen extractos de Curcuma longa y Equinácea angustifolia que son útiles para reducir la inflamación y el dolor periféricos
CN100579535C (zh) 免疫功能以及与之有关的改善
Sharma et al. Anticancer therapeutic potential of silibinin: current trends, scope and relevance
US8092845B2 (en) Anti-inflammatory extract and agent and method for the production thereof
ES2590209T3 (es) Composiciones para el tratamiento de la fatiga asociada al cáncer
ES2358420T3 (es) Cápsula blanda de nlkj (lípidos neutros obtenidos de semillas de lágrimas de job) para el tratamiento de enfermedades de la próstata.
HK1078471B (en) Improvements in or relating to immune functions
Mohajeri et al. Curcumin as a Natural Therapeutic Agent: A Rapid Review of Potential Clinical Uses and Mechanisms of Action
RU2007116726A (ru) Применение лавандового масла для профилактики и лечения неврастении, соматических нарушений и других болезней, связанных со стрессом
Sekhar et al. A review on anticancer potential of natural drugs: hispolon and limonene
JP2015214530A (ja) 胃腸薬組成物
Ekeuku et al. Skeletal protective effect of Coenzyme Q10: A review
Bawa et al. Clinical Uses of Piperine: A Review
EP4304621A1 (en) Herbal extract formula for treating coronavirus infection
Aloqbi Recent Updates on Unravelling the Therapeutic Potential of Ginger Bioactive Compounds in Cancer Management.
Abdelkader et al. Rhizomatous plants: Curcuma longa and Zingiber officinale in affording immunity
S. Kataki et al. Women’s Ginseng (Angelica sinensis): an ethnopharmacological dossier
US12364725B2 (en) Methods of inhibiting cancer growth and inhibiting viral infections
CN103142928A (zh) 骨筋口服液及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1078471

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1078471

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100113

Termination date: 20110109